Significantly greater mean declines in HBsAg levels (p <0.017) were seen in those receiving imdusiran, VTP-300 and low-dose nivolumab compared…
The amivantamab plus lazertinib combination regimen offers potential to provide new standard of care as first-line option for adult patients…
The U.S. healthcare revenue cycle management (RCM) outsourcing market for outpatient and ancillary services is experiencing significant growth. In 2023,…
With Growing Demand in Zero Proof and Bubbly Drinks, New Dealcoholized Sparkling Brut and Sparkling Rosé Hit the Spot BOSTON,…
Ginkgo provides update on its restructuring process including an acceleration of site consolidation initiatives and continued progress on cost reductions…
SALT LAKE CITY, Nov. 7, 2024 /PRNewswire/ -- Nuvia Dental Implant Centers, a national leader in advanced dental implant solutions,…
BOSTON, Nov. 12, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and…
Leading Company Focused on ABA Therapy for Preschool Children with Autism Expands Leadership TeamCHICAGO, Nov. 12, 2024 (GLOBE NEWSWIRE) --…
Conference call will be held today, Tuesday, November 12 at 9:00 am ETCARMEL, Ind., Nov. 12, 2024 (GLOBE NEWSWIRE) --…
SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pre-commercial…